FIELD: organic chemistry, medicine.
SUBSTANCE: compounds of formula I 
are disclosed, wherein R1, R2, R3, R4, R5, R6, R7, R41, R42, R43, R44, R45, R46, A, and B are as described in description.
EFFECT: new compounds with increased electrophysiological activity useful in treatment of cardiac arrhythmias.
132 cl, 1 tbl, 37 ex
| Title | Year | Author | Number |
|---|---|---|---|
| 3,7-DIAZABICYCLO[3.3.0]OCTANES AND THEIR USING IN TREATMENT OF CARDIAC ARRHYTHMIA | 2002 |
|
RU2293085C2 |
| AZABICYCLOOCTANE DERIVATIVE, PHARMACEUTICAL PREPARATIONS, METHOD FOR PROPHYLAXIS OR TREATMENT, METHODS FOR PREPARING COMPOUNDS, COMPOUNDS | 2000 |
|
RU2262505C2 |
| 3,7-DIAZABICYCLO[3,3,1]-CONTAINING PREPARATIONS AS ANTI-ARRHYTHMIC COMPOUNDS | 2002 |
|
RU2286993C2 |
| INTERMEDIATE CHEMICAL COMPOUND | 2003 |
|
RU2326122C2 |
| SUBSTITUTED 3,7-DIAZABICYCLO[3,3,1]NONANES, FOCUSED LIBRARY AND COMBINATORY LIBRARY | 2003 |
|
RU2228934C1 |
| DERIVATIVES OF 3-SUBSTITUTED 1,5-DIPHENYLPYRAZOLE EFFECTIVE AS CB1 MODULATORS | 2005 |
|
RU2375349C2 |
| LIGAND AND COMPLEX FOR CATALYTIC WHITENING SUBSTRATE | 2001 |
|
RU2283342C2 |
| AMIDES OF DIASABICYCLOALKANES, SELECTIVE WITH RESPECT TO ACETYLCHOLINE SUBTYPE OF NICOTINIC RECEPTORS | 2007 |
|
RU2517693C2 |
| PHARMACEUTICAL COMPOSITION, CONTAINING ANTAGONIST P2X OF RECEPTOR AND FACTOR OF TUMOUR NECROSIS α | 2004 |
|
RU2350354C2 |
| DERIVATIVES OF NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS, METHODS FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHODS FOR TREATMENT OF INFLAMMATORY DISEASES AND RESPIRATORY WAYS DISEASES | 2001 |
|
RU2265011C2 |
